Evidence map›Paper›PMID 34138976›Full record

ArticlePLoS pathogens2021

Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection.

Liliana Echavarría-Consuegra, Georgia M Cook, Idoia Busnadiego, Charlotte Lefèvre, Sarah Keep, Katherine Brown, Nicole Doyle, Giulia Dowgier, Krzysztof Franaszek, Nathan A Moore and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
8.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Liliana Echavarría-ConsuegraDivision of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.ORCID 0000-0002-9024-3860
Georgia M CookDivision of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.ORCID 0000-0003-1577-735X
Idoia BusnadiegoInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-8781-9099
Charlotte LefèvreDivision of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.ORCID 0000-0002-0762-7223
Sarah KeepThe Pirbright Institute, Woking, Surrey, United Kingdom.ORCID 0000-0001-9583-630X
Katherine BrownDivision of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.ORCID 0000-0002-8400-6922
Nicole DoyleThe Pirbright Institute, Woking, Surrey, United Kingdom.ORCID 0000-0002-6016-5830
Giulia DowgierThe Pirbright Institute, Woking, Surrey, United Kingdom.ORCID 0000-0001-6738-5097
Krzysztof FranaszekDivision of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.
Nathan A MooreDepartment of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-4279-2443
Stuart G SiddellDepartment of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-8702-7868
Erica BickertonThe Pirbright Institute, Woking, Surrey, United Kingdom.ORCID 0000-0002-4012-1283
Benjamin G HaleInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-3891-9480
Andrew E FirthDivision of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.
Ian BrierleyDivision of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.
Nerea IrigoyenDivision of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.ORCID 0000-0001-6346-3369
University of Cambridge · GBThe Pirbright Institute · GBUniversity of Bristol · GBUniversity of Zurich · CH

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/00007034Biotechnology and Biological Sciences Research Council BBS/E/I/00007037European Research Council 646891Medical Research Council MR/M011747/1Wellcome TrustWellcome Trust 106207Wellcome Trust 202797/Z/16/ZWellcome Trust 203864/Z/16/Z
6 · The paper itself

Abstract

Coronavirus infection induces the unfolded protein response (UPR), a cellular signalling pathway composed of three branches, triggered by unfolded proteins in the endoplasmic reticulum (ER) due to high ER load. We have used RNA sequencing and ribosome profiling to investigate holistically the transcriptional and translational response to cellular infection by murine hepatitis virus (MHV), often used as a model for the Betacoronavirus genus to which the recently emerged SARS-CoV-2 also belongs. We found the UPR to be amongst the most significantly up-regulated pathways in response to MHV infection. To confirm and extend these observations, we show experimentally the induction of all three branches of the UPR in both MHV- and SARS-CoV-2-infected cells. Over-expression of the SARS-CoV-2 ORF8 or S proteins alone is itself sufficient to induce the UPR. Remarkably, pharmacological inhibition of the UPR greatly reduced the replication of both MHV and SARS-CoV-2, revealing the importance of this pathway for successful coronavirus replication. This was particularly striking when both IRE1α and ATF6 branches of the UPR were inhibited, reducing SARS-CoV-2 virion release (~1,000-fold). Together, these data highlight the UPR as a promising antiviral target to combat coronavirus infection.

Indexed as

COVID-19 Drug TreatmentActivating Transcription Factor 6AnimalsAntiviral AgentsCell LineChlorocebus aethiopsDrug Delivery SystemsEndoribonucleasesHEK293 CellsHumansMiceMurine hepatitis virusProtein Serine-Threonine KinasesRNA-SeqUnfolded Protein ResponseVero CellsActivating Transcription Factor 6Antiviral AgentsAtf6 protein, mouseEndoribonucleasesErn1 protein, mouseProtein Serine-Threonine KinasesViral Proteins

Identifiers

PMID34138976
PMCPMC8211288
OpenAlexW3170102411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.